Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Slaets

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|June 24, 2015
Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosisKris Janssens, Helena Slaets, Niels Hellings
Brain, Behavior, and Immunity|March 9, 2023
Train your T cells: How skeletal muscles and T cells keep each other fit during agingHelena Slaets, Lena Fonteyn, Bert O Eijnde, et al.
Trends in Molecular Medicine|September 28, 2010
Therapeutic potential of LIF in multiple sclerosisHelena Slaets, Jerome J A Hendriks, Piet Stinissen, et al.
Aging Cell|August 8, 2024
Are immunosenescent T cells really senescent?Helena Slaets, Naomi Veeningen, Peter L J de Keizer, et al.
Mechanisms of Ageing and Development|July 1, 2024
Navigating oligodendrocyte precursor cell aging in brain healthFreddy Leenders, Lisa Koole, Helena Slaets, et al.
Cell Transplantation|December 22, 2015
Tolerogenic Dendritic Cells Generated by In Vitro Treatment With SAHA Are Not Stable In VivoKristof Thewissen, Bieke Broux, Jerome J A Hendriks, et al.
Journal of Neuroimmunology|December 1, 2012
Systemic treatment with the inhibitory neurotransmitter γ-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responsesSofie Carmans, Jerome J A Hendriks, Helena Slaets, et al.
Molecular Neurobiology|July 6, 2014
Oncostatin M reduces lesion size and promotes functional recovery and neurite outgrowth after spinal cord injuryHelena Slaets, Sofie Nelissen, Kris Janssens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2010
CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosisHelena Slaets, Jerome J A Hendriks, Chris Van den Haute, et al.
Proteomics|March 15, 2008
Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3Helena Slaets, Debora Dumont, Joris Vanderlocht, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|June 24, 2015
Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosisKris Janssens, Helena Slaets, Niels Hellings
Brain, Behavior, and Immunity|March 9, 2023
Train your T cells: How skeletal muscles and T cells keep each other fit during agingHelena Slaets, Lena Fonteyn, Bert O Eijnde, et al.
Trends in Molecular Medicine|September 28, 2010
Therapeutic potential of LIF in multiple sclerosisHelena Slaets, Jerome J A Hendriks, Piet Stinissen, et al.
Aging Cell|August 8, 2024
Are immunosenescent T cells really senescent?Helena Slaets, Naomi Veeningen, Peter L J de Keizer, et al.
Mechanisms of Ageing and Development|July 1, 2024
Navigating oligodendrocyte precursor cell aging in brain healthFreddy Leenders, Lisa Koole, Helena Slaets, et al.
Cell Transplantation|December 22, 2015
Tolerogenic Dendritic Cells Generated by In Vitro Treatment With SAHA Are Not Stable In VivoKristof Thewissen, Bieke Broux, Jerome J A Hendriks, et al.
Journal of Neuroimmunology|December 1, 2012
Systemic treatment with the inhibitory neurotransmitter γ-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responsesSofie Carmans, Jerome J A Hendriks, Helena Slaets, et al.
Molecular Neurobiology|July 6, 2014
Oncostatin M reduces lesion size and promotes functional recovery and neurite outgrowth after spinal cord injuryHelena Slaets, Sofie Nelissen, Kris Janssens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2010
CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosisHelena Slaets, Jerome J A Hendriks, Chris Van den Haute, et al.
Proteomics|March 15, 2008
Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3Helena Slaets, Debora Dumont, Joris Vanderlocht, et al.
Pageof 2